A new study published in the Journal of Affective Disorders has shown that the mental health benefits of psilocybin, the main psychoactive compound found in magic mushrooms, may vary significantly depending on a person’s race. Researchers recruited almost 3,000 people in the US who planned to [...]
Scientists at the University of South Australia say they have developed an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases. Cannabidiol (CBD), the non-psychoactive compound found in the cannabis plant, is widely prescribed for its analgesic, anti-inflammatory [...]
France’s four-year campaign to launch a fully regulated generalised medical cannabis framework is finally being realised. Just weeks ago thousands of participants in Frances’ medical cannabis ‘experiment’, launched in 2021, were preparing to wean themselves off the treatment and had been instructed by the government to [...]
The cannabis sector faces a multifaceted landscape marked by economic challenges, shifting regulations and market volatility. Thriving in this environment requires industry businesses to move beyond reactive measures, embracing forward-looking risk management strategies. By adopting comprehensive mitigation plans and maintaining proactive vigilance, cannabis companies can stay [...]
A four-year study, published in the journal Drug and Alcohol Dependence, has found that teenagers are not put off by the negative effects of alcohol. Researchers followed over 12,700 students aged 12 to 15 from 105 schools across Northern Ireland and Scotland to assess how early [...]
UK adults remain confused about the legal status and availability of medical cannabis, despite it being legalised in 2018, a new survey has revealed. According to a new study of 2,000 adults, while four in every five respondents (79%) were aware of medical cannabis, only 26% [...]
Patients who are living with hypermobility disorders report significant improvements in pain management, sleep quality, and anxiety levels after using cannabis-based medicinal products (CBMPs), according to new research published in the journal ACR Open Rheumatology. Researchers from Imperial College London and the Curaleaf Clinic analysed data [...]
Releaf is one of the first medical cannabis clinics to integrate with the NHS’ Spine service, the digital backbone of healthcare across the UK. Could this be a turning point in how clinicians view and engage with cannabis-based medicines? While the number of prescriptions for CBMPs [...]
New analysis of wastewater samples has shown significant increases in the number of people consuming party drugs, a Home Office report has shown. The study, which analysed wastewater from treatment plants covering 25% of England’s population, found that Ketamine use in England has surged by 85% [...]
Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the 1971 Convention. After over a year of warnings from various international health bodies and individual efforts from a swathe of countries [...]
A study has shown that the decriminalisation of cannabis in the US city of Atlanta led to a significant decrease in violent crime, contradicting initial fears from critics of the policy. Data showed that violent crime rates fell by nearly 20 per cent after the city [...]
A new study has found certain cannabis terpenes to be effective at relieving post-surgical and fibromyalgia pain in preclinical models. Research from the University of Arizona Health Sciences and funded by the National Institute of Health, suggests that terpenes from the Cannabis sativa plant may be [...]
The concept of the medical cannabis card originated out of the US in some jurisdictions where patients are issued an annual card from their doctor which permits them to purchase medical cannabis from any legal dispensary. Although the markets in Europe differ significantly to those in [...]
Written by SOMAÍ Pharmaceuticals CEO, Michael Sassano For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market evolves, established cannabis brands are playing an increasingly critical role in patient care, physician confidence, and regulatory acceptance, mirroring [...]
Scientists have developed a new compound to harnesses the pain-relieving properties of cannabis without any unwanted side effects, pointing to a possible alternative to opioids. In the search for alternative pain relievers, researchers at Washington University School of Medicine in St. Louis and Stanford University have [...]
In a new survey of UK doctors, 84% said they would be open to prescribing medical cannabis for chronic pain if it were part of the NHS toolkit. The findings indicate there may be significant support among doctors for widening access to medical cannabis for the [...]
Network Rail’s policy breaches the Equality Act 2010. PatientsCann UK fights for fair treatment—take action now.
The post Network Rail’s Response to Our Concerns: A Call for Fair and Transparent Policy first appeared on PatientsCann UK.
When it comes to medical cannabis, quality and consistency aren’t just nice-to-haves, they’re the whole deal. Patients depend on it to manage conditions like epilepsy, chronic pain, and PTSD, not for a surprise mystery grab bag of effects. If potency or purity wavers, so does the treatment, and that’s a no-go. A rock-solid supply chain […]
The post Why Your Medical Cannabis Shouldn’t Be a Game of Chance! appeared first on I Am Billy.
Yep, you can hit the road with your prescribed medical cannabis – but there are a few golden rules: • You must not be impaired (no zombie-mode driving). • Your prescription comes from a specialist consultant (not your mate Dave). • You can prove it (because “trust me, bro” won’t cut it). The DVLA says doctors should clue […]
The post Driving on Medical Cannabis UK: Can You? appeared first on I Am Billy.
The government is currently tinkering with disability benefits, but for millions of disabled folks, these aren’t just numbers on a spreadsheet, they’re the difference between making it through the month or free-falling into financial chaos. They are taking away a lifeline! Picture this: You rely on medical cannabis to keep your epilepsy, multiple sclerosis, or […]
The post The Terrifying High Price of Cutting Disability Benefits & Medical Cannabis in the UK appeared first on I Am Billy.
The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers, have been published by a local university. Just days after Switzerland announced it was positioning itself to become the first European country to launch a full commercial adult-use [...]
A survey has revealed that 84% of UK doctors would be willing to prescribe medical cannabis to manage chronic pain if it were part of the NHS toolkit. The research, commissioned by medical cannabis clinic Alternaleaf, comes as experts warn that the number of chronic pain [...]
Europe’s largest cannabis trade show and fair, Spannabis, has announced that its March 2025 event will be the last to be hosted in Barcelona. The event, which attracts tens of thousands of people from around the world, has been held in the Spanish city of Barcelona [...]
In a new research paper, mothers using medical cannabis to manage their health say it helps them to be ‘more present’ and ‘tolerant’ parents. A new study, funded by the Health Research Council of New Zealand, has explored the experiences of mothers using medical cannabis to [...]
A new study is shaking things up! Turns out, prescription cannabis might just be the ultimate life hack for folks 50 and older struggling with pain and sleep issues. Researchers found that prescription cannabis isn’t just safe but actually effective in easing pain, improving sleep, and boosting overall quality of life. The Highlights: 229 participants […]
The post Breaking: Grandparents & Prescription Cannabis appeared first on I Am Billy.
Cannabinoid therapy is the rising star of pain relief, nausea control, and neurological care. But here’s a fun fact – if your liver is running on low power (thanks to cirrhosis, hepatitis, or other party-crashers), your cannabinoid dose might need a remix! Your liver is the backstage crew for metabolizing THC and CBD, mainly using […]
The post Cannabinoid Therapy & Liver Health: Why One Size Doesn’t Fit All appeared first on I Am Billy.
OxyContin was introduced in 1996 as a revolutionary painkiller, with Purdue Pharma assuring doctors and patients that it was safe and had a low risk of addiction. This was a blatant lie. The drug was a powerful opioid, chemically similar to heroin, and highly addictive. Purdue’s aggressive marketing campaign targeted not only chronic pain patients […]
The post What if we had Ditched Deadly OxyContin and Embraced Live-Giving Alternatives Instead? appeared first on I Am Billy.
Analysis released by Transform Drug Policy Foundation has shown that that legalising and regulating cannabis for adult non-medical use in the UK could generate up to £1.5 billion in annual net benefits to the Treasury. The report, titled High Returns: The Economic Benefits of UK Cannabis [...]
According to the results of a study published recently in the Journal of Safety Research, taking prescribed cannabis before the start of a journey does not affect the ability of patients to drive safely. In the study, funded by the Motor Accident Insurance Commission, Australian researchers [...]
A Manchester-based charity called CannCare has announced it will provide support to medical cannabis patients in the UK facing discrimination after a rise in reported issues. The charity, which opened its doors on 1 March, offers assistance to patients using cannabis-based products for medicinal use (CBPMs) [...]
Drug policy experts have backed a family’s call for regulatory reform to protect patients travelling to Ireland with legal cannabis medication. Jason Pickering was making the trip to Ireland to visit his late father’s grave, when his cannabis medication was seized at Dublin Airport on 23 [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
